JG
EVH icon

Jain Global’s Evolent Health EVH Stock Holding History

Jain Global’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
55,465
+14,237
+35% +$54.6K ﹤0.01% 1388
2026
Q1 		$94K Sell
41,228
-63,816
-61% -$202K ﹤0.01% 1130
2025
Q4 		$420K Buy
+105,044
New +$584K ﹤0.01% 873
2025
Q1 		– Sell
-29,841
Closed -$336K – 1155
2024
Q4 		$336K Buy
+29,841
New +$524K 0.01% 536

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jain Global's EVH Position: Q2 2026 in Review

Jain Global increased its Evolent Health (EVH) stake by 35% in Q2 2026, buying an estimated $54.6K and bringing the position to 55,465 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

Jain Global first reported a position in EVH in Q4 2024 and has held it in 4 quarters since. The position peaked at $420K in Q4 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Jain Global held 55,465 shares of Evolent Health worth $301K as of Q2 2026.
  • Jain Global bought 14,237 Evolent Health shares in Q2 2026, an estimated $54.6K.
  • Evolent Health made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1388 holding.
  • Jain Global first reported a position in Evolent Health in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Evolent Health position peaked at $420K in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.